Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia.
Katherine J BangenDenis S SmirnovLisa Delano-WoodChristina E WierengaMark W BondiDavid P SalmonDouglas GalaskoPublished in: Alzheimer's research & therapy (2021)
The findings suggest that pulse wave velocity, a non-invasive method to assess arterial wall properties, may be a useful marker of risk for cognitive decline, particularly among individuals who are APOE ε4 carriers or CSF AD biomarke0r-positive.